Authors:
Querido, E
Blanchette, P
Yan, Q
Kamura, T
Morrison, M
Boivin, D
Kaelin, WG
Conaway, RC
Conaway, JW
Branton, PE
Citation: E. Querido et al., Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism, involving a Cullin-containing complex, GENE DEV, 15(23), 2001, pp. 3104-3117
Authors:
Ota, S
Sugiyama, T
Komai, K
Hirai, N
Kumagai, S
Ushijima, K
Nishida, T
Kamura, T
Citation: S. Ota et al., Weekly 1 hour paclitaxel infusion in patients with recurrent gynecologicaltumors: a pilot study, JPN J CLIN, 31(8), 2001, pp. 395-398
Authors:
Kaku, T
Yoshikawa, H
Tsuda, H
Sakamoto, A
Fukunaga, M
Kuwabara, Y
Hataeg, M
Kodama, S
Kuzuya, K
Sato, S
Nishimura, T
Hiura, M
Nakano, H
Iwasaka, T
Miyazaki, K
Kamura, T
Citation: T. Kaku et al., Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome, CANCER LETT, 167(1), 2001, pp. 39-48
Authors:
Akahira, JI
Yoshikawa, H
Shimizu, Y
Tsunematsu, R
Hirakawa, T
Kuramoto, H
Shiromizu, K
Kuzuya, K
Kamura, T
Kikuchi, Y
Kodama, S
Yamamoto, K
Sato, S
Citation: Ji. Akahira et al., Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study, GYNECOL ONC, 81(3), 2001, pp. 398-403
Authors:
Sugiyama, T
Hasuo, Y
Nishida, T
Kamura, T
Citation: T. Sugiyama et al., Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer, GYNECOL ONC, 81(2), 2001, pp. 330-331
Authors:
Kamura, T
Burian, D
Yan, Q
Schmidt, SL
Lane, WS
Querido, E
Branton, PE
Shilatifard, A
Conaway, RC
Conaway, JW
Citation: T. Kamura et al., MUF1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase, J BIOL CHEM, 276(32), 2001, pp. 29748-29753
Authors:
Kamura, T
Burian, D
Khalili, H
Schmidt, SL
Sato, S
Liu, WJ
Conrad, MN
Conaway, RC
Conaway, JW
Shilatifard, A
Citation: T. Kamura et al., Cloning and characterization of ELL-associated proteins EAP45 and EAP20 - A role for yeast EAP-like proteins in regulation of gene expression by glucose, J BIOL CHEM, 276(19), 2001, pp. 16528-16533
Authors:
Matsuzaka, H
Kamura, T
Ariga, K
Okubo, T
Ishii, T
Yamashita, M
Kondo, M
Kitagawa, S
Citation: H. Matsuzaka et al., Synthesis and molecular structure of the amido-bridged dinuclear rhodium complex [CpRh{mu(2)-(NH)(2)C10H6-2,3}(mu(2)-Cl)RhCp*][PF6] (Cp* = eta(5)-C5Me5), MOLEC CRYST, 342, 2000, pp. 1-6
Authors:
Shigematsu, T
Kamura, T
Arima, T
Wake, N
Nakano, H
Citation: T. Shigematsu et al., DNA polymorphism analysis of a pure non-gestational choriocarcinoma of theovary: case report, EUR J GYN O, 21(2), 2000, pp. 153-154
Authors:
Ota, S
Sugiyama, T
Ushijima, K
Komai, K
Fujiyoshi, K
Hirai, N
Nishida, T
Kamura, T
Citation: S. Ota et al., Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel, CANCER LETT, 160(1), 2000, pp. 9-12
Authors:
Matsuzaka, H
Kamura, T
Ariga, K
Watanabe, Y
Okubo, T
Ishii, T
Yamashita, M
Kondo, M
Kitagawa, S
Citation: H. Matsuzaka et al., Preparation, structure, and reactivities of amido-bridged dinuclear rhodium(III) and rhodium(II) complexes, ORGANOMETAL, 19(3), 2000, pp. 216-218
Authors:
Ogawa, S
Kaku, T
Amada, S
Kobayashi, H
Hirakawa, T
Ariyoshi, K
Kamura, T
Nakano, H
Citation: S. Ogawa et al., Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study, GYNECOL ONC, 77(2), 2000, pp. 298-304
Authors:
Kamura, T
Sato, S
Iwai, K
Czyzyk-Krzeska, M
Conaway, RC
Conaway, JW
Citation: T. Kamura et al., Activation of HIF1 alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex, P NAS US, 97(19), 2000, pp. 10430-10435
Authors:
Kawano, K
Gomi, S
Tanaka, K
Tsuda, N
Kamura, T
Itoh, K
Yamada, A
Citation: K. Kawano et al., Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer, CANCER RES, 60(13), 2000, pp. 3550-3558
Authors:
Sugiyama, T
Kamura, T
Kigawa, J
Terakawa, N
Kikuchi, Y
Kita, T
Suzuki, W
Sato, I
Taguchi, K
Citation: T. Sugiyama et al., Clinical characteristics of clear cell carcinoma of the ovary - A distincthistologic type with poor prognosis and resistance to platinum-based chemotherapy, CANCER, 88(11), 2000, pp. 2584-2589
Authors:
Kaku, T
Sonoda, K
Kamura, T
Hirakawa, T
Sakai, K
Amada, S
Ogawa, S
Kobayashi, H
Nakashima, M
Watanabe, T
Nakano, H
Citation: T. Kaku et al., The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix, CLIN CANC R, 5(6), 1999, pp. 1449-1453
Authors:
Kamura, T
Sakai, K
Kaku, T
Kobayashi, H
Mitsumoto, M
Tsuneyoshi, M
Nakano, H
Citation: T. Kamura et al., Comparison of p53 and CD44 variant 6 expression between paired primary andrecurrent ovarian cancer: An immunohistochemical analysis, ONCOL REP, 6(1), 1999, pp. 97-101
Citation: T. Kamura et al., The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2, GENE DEV, 13(22), 1999, pp. 2928-2933
Authors:
Hirakawa, T
Kamura, T
Kaku, T
Amada, S
Ariyoshi, K
Kinukawa, N
Nakano, H
Citation: T. Hirakawa et al., Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix, GYNECOL ONC, 74(3), 1999, pp. 369-374
Authors:
Sakai, K
Kaku, T
Kamura, T
Kinukawa, N
Amada, S
Shigematsu, T
Hirakawa, T
Kobayashi, H
Ariyoshi, K
Nakano, H
Citation: K. Sakai et al., Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 360-366
Authors:
Kaku, T
Kamura, T
Hirakawa, T
Sakai, K
Amada, S
Kobayashi, H
Nakano, H
Citation: T. Kaku et al., Endometrial carcinoma associated with hyperplasia - Immunohistochemical study of angiogenesis and p53 expression, GYNECOL ONC, 72(1), 1999, pp. 51-55